233 related articles for article (PubMed ID: 12915872)
1. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients.
Peintinger F; Reitsamer R; Stranzl H; Ralph G
Br J Cancer; 2003 Aug; 89(4):648-52. PubMed ID: 12915872
[TBL] [Abstract][Full Text] [Related]
2. A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.
Kootstra JJ; Hoekstra-Weebers JE; Rietman JS; de Vries J; Baas PC; Geertzen JH; Hoekstra HJ
Ann Surg Oncol; 2010 Sep; 17(9):2384-94. PubMed ID: 20221902
[TBL] [Abstract][Full Text] [Related]
3. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
4. Quality of life after sentinel lymph node biopsy or axillary lymph node dissection in stage I/II breast cancer patients: a prospective longitudinal study.
Kootstra J; Hoekstra-Weebers JE; Rietman H; de Vries J; Baas P; Geertzen JH; Hoekstra HJ
Ann Surg Oncol; 2008 Sep; 15(9):2533-41. PubMed ID: 18597146
[TBL] [Abstract][Full Text] [Related]
5. Impact of modern-day axillary treatment on patient reported arm morbidity and physical functioning in breast cancer patients.
Gregorowitsch ML; Verkooijen HM; Houweling A; Fuhler N; Koelemij R; Schoenmaeckers EJP; Sier MF; Ernst MF; Witkamp AJ; Van Dalen T; Young-Afat DA; van den Bongard DHJG;
Radiother Oncol; 2019 Feb; 131():221-228. PubMed ID: 30033384
[TBL] [Abstract][Full Text] [Related]
6. Quality of life after axillary or groin sentinel lymph node biopsy, with or without completion lymph node dissection, in patients with cutaneous melanoma.
de Vries M; Hoekstra HJ; Hoekstra-Weebers JE
Ann Surg Oncol; 2009 Oct; 16(10):2840-7. PubMed ID: 19639366
[TBL] [Abstract][Full Text] [Related]
7. Quality-of-life impact of sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients.
Belmonte R; Garin O; Segura M; Pont A; Escalada F; Ferrer M
Value Health; 2012; 15(6):907-15. PubMed ID: 22999141
[TBL] [Abstract][Full Text] [Related]
8. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
Crane-Okada R; Wascher RA; Elashoff D; Giuliano AE
Ann Surg Oncol; 2008 Jul; 15(7):1996-2005. PubMed ID: 18415650
[TBL] [Abstract][Full Text] [Related]
9. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer.
Burak WE; Hollenbeck ST; Zervos EE; Hock KL; Kemp LC; Young DC
Am J Surg; 2002 Jan; 183(1):23-7. PubMed ID: 11869698
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal study of shoulder and arm morbidity in breast cancer survivors 7 years after sentinel lymph node biopsy or axillary lymph node dissection.
Kootstra JJ; Dijkstra PU; Rietman H; de Vries J; Baas P; Geertzen JH; Hoekstra HJ; Hoekstra-Weebers JE
Breast Cancer Res Treat; 2013 May; 139(1):125-34. PubMed ID: 23588950
[TBL] [Abstract][Full Text] [Related]
12. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial.
Del Bianco P; Zavagno G; Burelli P; Scalco G; Barutta L; Carraro P; Pietrarota P; Meneghini G; Morbin T; Tacchetti G; Pecoraro P; Belardinelli V; De Salvo GL;
Eur J Surg Oncol; 2008 May; 34(5):508-13. PubMed ID: 17614245
[TBL] [Abstract][Full Text] [Related]
13. Impact of sentinel node biopsy on long-term quality of life in breast cancer patients.
De Gournay E; Guyomard A; Coutant C; Boulet S; Arveux P; Causeret S; Gouy S; Padeano MM; Loustalot C; Sauzedde JM; Smail M; Combier JP; Chevillote P; Rosburger C; Bonnetain F; Fraisse J; Dabakuyo-Yonli TS
Br J Cancer; 2013 Nov; 109(11):2783-91. PubMed ID: 24169352
[TBL] [Abstract][Full Text] [Related]
14. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
[TBL] [Abstract][Full Text] [Related]
15. A multicenter cohort study to compare quality of life in breast cancer patients according to sentinel lymph node biopsy or axillary lymph node dissection.
Dabakuyo TS; Fraisse J; Causeret S; Gouy S; Padeano MM; Loustalot C; Cuisenier J; Sauzedde JM; Smail M; Combier JP; Chevillote P; Rosburger C; Boulet S; Arveux P; Bonnetain F
Ann Oncol; 2009 Aug; 20(8):1352-61. PubMed ID: 19468032
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
Sávolt Á; Cserni G; Lázár G; Maráz R; Kelemen P; Kovács E; Győrffy B; Udvarhelyi N; Vörös A; Ormándi K; Mátrai Z
Eur J Surg Oncol; 2019 Oct; 45(10):1835-1838. PubMed ID: 31126680
[TBL] [Abstract][Full Text] [Related]
17. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer.
Rietman JS; Dijkstra PU; Geertzen JH; Baas P; de Vries J; Dolsma WV; Groothoff JW; Eisma WH; Hoekstra HJ
Ann Surg Oncol; 2004 Nov; 11(11):1018-24. PubMed ID: 15525832
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported outcomes one year after positive sentinel lymph node biopsy with or without axillary lymph node dissection in the randomized SENOMAC trial.
Appelgren M; Sackey H; Wengström Y; Johansson K; Ahlgren J; Andersson Y; Bergkvist L; Frisell J; Lundstedt D; Rydén L; Sund M; Alkner S; Vrou Offersen B; Filtenborg Tvedskov T; Christiansen P; de Boniface J;
Breast; 2022 Jun; 63():16-23. PubMed ID: 35279508
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of shoulder strength, shoulder range of motion, and lymphedema in breast cancer patients from pre-surgery to 5 years after ALND or SLNB.
Belmonte R; Messaggi-Sartor M; Ferrer M; Pont A; Escalada F
Support Care Cancer; 2018 Sep; 26(9):3277-3287. PubMed ID: 29651594
[TBL] [Abstract][Full Text] [Related]
20. Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database.
Yi M; Giordano SH; Meric-Bernstam F; Mittendorf EA; Kuerer HM; Hwang RF; Bedrosian I; Rourke L; Hunt KK
Ann Surg Oncol; 2010 Oct; 17 Suppl 3(0 3):343-51. PubMed ID: 20853057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
